Trexquant Investment LP trimmed its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 98.9% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 859 shares of the company's stock after selling 75,521 shares during the period. Trexquant Investment LP's holdings in HCA Healthcare were worth $297,000 at the end of the most recent reporting period.
Several other large investors have also recently bought and sold shares of the company. Landscape Capital Management L.L.C. boosted its holdings in HCA Healthcare by 15.0% in the 1st quarter. Landscape Capital Management L.L.C. now owns 2,698 shares of the company's stock valued at $932,000 after purchasing an additional 352 shares during the period. OMERS ADMINISTRATION Corp boosted its holdings in HCA Healthcare by 2.7% in the 1st quarter. OMERS ADMINISTRATION Corp now owns 13,414 shares of the company's stock valued at $4,635,000 after purchasing an additional 347 shares during the period. B. Metzler seel. Sohn & Co. AG lifted its holdings in shares of HCA Healthcare by 9.9% during the 1st quarter. B. Metzler seel. Sohn & Co. AG now owns 15,082 shares of the company's stock worth $5,212,000 after acquiring an additional 1,363 shares during the last quarter. RB Capital Management LLC lifted its holdings in shares of HCA Healthcare by 1.3% during the 1st quarter. RB Capital Management LLC now owns 3,012 shares of the company's stock worth $1,041,000 after acquiring an additional 40 shares during the last quarter. Finally, Ieq Capital LLC lifted its holdings in shares of HCA Healthcare by 46.0% during the 1st quarter. Ieq Capital LLC now owns 12,710 shares of the company's stock worth $4,392,000 after acquiring an additional 4,007 shares during the last quarter. 62.73% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of analysts have recently issued reports on HCA shares. Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Cantor Fitzgerald reiterated an "overweight" rating and issued a $444.00 target price on shares of HCA Healthcare in a research report on Tuesday, August 26th. Morgan Stanley decreased their target price on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a research report on Monday, July 28th. Robert W. Baird lifted their target price on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a research report on Thursday, August 14th. Finally, JPMorgan Chase & Co. lifted their target price on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a research report on Monday, August 4th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat, HCA Healthcare has a consensus rating of "Moderate Buy" and a consensus target price of $403.17.
Check Out Our Latest Research Report on HCA
Insider Buying and Selling
In related news, EVP Michael S. Cuffe sold 3,836 shares of the business's stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares of the company's stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.30% of the stock is owned by insiders.
HCA Healthcare Trading Up 0.7%
Shares of NYSE HCA traded up $2.69 during midday trading on Friday, hitting $405.54. 761,184 shares of the company traded hands, compared to its average volume of 1,129,364. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $420.98. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The stock has a 50-day moving average price of $382.88 and a 200 day moving average price of $362.77. The firm has a market cap of $94.89 billion, a P/E ratio of 17.05, a P/E/G ratio of 1.27 and a beta of 1.41.
HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same quarter in the previous year, the firm posted $5.50 earnings per share. HCA Healthcare's quarterly revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.
HCA Healthcare Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be paid a dividend of $0.72 per share. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare's payout ratio is presently 12.11%.
HCA Healthcare Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Articles

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.